Cytek Biosciences Ownership | Who Owns Cytek Biosciences?

Overview Forecast RevenueFinancials Chart Transcripts

Cytek Biosciences Ownership Summary

Cytek Biosciences is owned by 57.23% institutional investors, 8.80% insiders, and 33.97% retail investors. Blackrock is the largest institutional shareholder, holding 13.04% of CTKB shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.23% of its assets in Cytek Biosciences shares.

CTKB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cytek Biosciences	57.23%	8.80%	33.97%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Medical Device Stocks	76.80%	8.19%	15.00%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	17.07M	13.04%	$95.25M
Vanguard group	11.75M	8.97%	$65.54M
Brown capital management	11.39M	8.70%	$63.54M
Hhlr advisors	6.66M	5.08%	$37.15M
State street	3.97M	3.03%	$22.17M
New york state common retirement fund	2.95M	2.25%	$16.45M
Geode capital management	2.58M	1.97%	$14.39M
Wellington management group llp	2.14M	1.63%	$11.92M
Dimensional fund advisors lp	1.47M	1.12%	$8.17M
Goldman sachs group	1.36M	1.04%	$7.57M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Brown capital management	11.39M	1.28%	$63.54M
Hhlr advisors	6.66M	0.92%	$37.15M
Algert global	295.27K	0.05%	$1.65M
Sherbrooke park advisers	29.98K	0.03%	$167.31K
State of wyoming	23.87K	0.02%	$133.20K
New york state common retirement fund	2.95M	0.02%	$16.45M
Connor, clark & lunn investment management	631.47K	0.01%	$3.52M
Dynamic technology lab private	23.47K	0.01%	$131.00K
Deerfield management company, l.p. (series c)	155.76K	0.01%	$869.13K
Trexquant investment lp	138.39K	0.01%	$772.24K

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	946.49K	0.00%	919.85K
Goldman sachs group	1.36M	0.00%	793.24K
Wellington management group llp	2.14M	0.00%	780.74K
Jpmorgan chase	608.44K	0.00%	523.03K
Renaissance	233.90K	0.00%	233.90K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-6.81M
Brown capital management	11.39M	1.28%	-634.63K
Divisadero street capital management, lp	-	-	-487.55K
Blackrock	17.07M	0.00%	-355.55K
Vanguard group	11.75M	0.00%	-266.63K

New Positions

Holder	Shares	% Assets	Change	Value
Renaissance	233.90K	0.00%	233.90K	$1.31M
Deerfield management company, l.p. (series c)	155.76K	0.01%	155.76K	$869.13K
Trexquant investment lp	138.39K	0.01%	138.39K	$772.24K
Corebridge financial	69.33K	0.00%	69.33K	$386.86K
Mirae asset global etfs	61.83K	0.00%	61.83K	$344.99K

Sold Out

Holder	Change
Mendota financial group	-13.00
Nelson, van denburg & campbell wealth management group	-24.00
Huntington national bank	-36.00
Eversource wealth advisors	-158.00
Clear street markets	-878.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	135	5.47%	74,969,791	-1.57%	57	1.70%	86	13.16%	31	-22.50%
Jun 30, 2024	126	3.28%	76,150,225	-5.51%	58	1.64%	75	17.19%	40	14.29%
Mar 31, 2024	122	19.61%	80,592,474	2.10%	59	1.77%	64	12.28%	35	16.67%
Dec 31, 2023	102	-5.56%	78,933,920	1.89%	57	1.78%	57	-20.83%	30	30.43%
Sep 30, 2023	108	3.85%	77,471,030	0.55%	56	1.76%	72	-2.70%	23	27.78%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	6.74M	5.23%	3.45K
Vanguard Total Stock Mkt Idx Inv	3.37M	2.61%	-
iShares Russell 2000 ETF	3.26M	2.53%	-12.53K
Vanguard Small Cap Index	2.62M	2.04%	-33.68K
Brown Capital Mgmt Small Co Inv	2.43M	1.89%	-1.46M
Vanguard Institutional Extnd Mkt Idx Tr	1.58M	1.23%	36.90K
Vanguard Small Cap Growth Index Inv	1.48M	1.15%	23.26K
Fidelity Small Cap Index	1.24M	0.96%	5.46K
iShares Russell 2000 Value ETF	1.15M	0.89%	-32.09K
iShares S&P Small-Cap 600 Value ETF	1.14M	0.88%	-

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	3
2024 Q1	-	2
2023 Q4	-	8

CTKB Ownership FAQ

Who Owns Cytek Biosciences?

Cytek Biosciences shareholders are primarily institutional investors at 57.23%, followed by 8.80% insiders and 33.97% retail investors. The average institutional ownership in Cytek Biosciences's industry, Medical Device Stocks, is 76.80%, which Cytek Biosciences falls below.

Who owns the most shares of Cytek Biosciences?

Cytek Biosciences’s largest shareholders are Blackrock (17.07M shares, 13.04%), Vanguard group (11.75M shares, 8.97%), and Brown capital management (11.39M shares, 8.70%). Together, they hold 30.71% of Cytek Biosciences’s total shares outstanding.

Does Blackrock own Cytek Biosciences?

Yes, BlackRock owns 13.04% of Cytek Biosciences, totaling 17.07M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 95.25M$. In the last quarter, BlackRock decreased its holdings by -356K shares, a -2.04% change.

Who is Cytek Biosciences’s biggest shareholder by percentage of total assets invested?

Brown capital management is Cytek Biosciences’s biggest shareholder by percentage of total assets invested, with 1.28% of its assets in 11.39M Cytek Biosciences shares, valued at 63.54M$.

Who is the top mutual fund holder of Cytek Biosciences shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Cytek Biosciences shares, with 5.23% of its total shares outstanding invested in 6.74M Cytek Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools